Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 22, 2025
Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV
Ilaria Facchi, Nicola Di Trani, Camden Caffey, et al.
Journal of Virology
|
September 15, 2007
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy
Zandrea Ambrose, Sarah Palmer, Valerie F Boltz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques
Fernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Protein Expression and Purification
|
October 24, 2021
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
Wen-Hsiang Chen, Jeroen Pollet, Ulrich Strych, et al.
NPJ Vaccines
|
July 21, 2024
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses
Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R Redd, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Nature Communications
|
June 11, 2026
Statewide multi-year wastewater sequencing reveals dual origins of HIV-1 signal
Justin R Clark, Dylan Chirman, Harihara Prakash, et al.
Vaccine
|
May 14, 2022
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 11, 2020
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Human Vaccines & Immunotherapeutics
|
April 13, 2021
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 22, 2025
Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV
Ilaria Facchi, Nicola Di Trani, Camden Caffey, et al.
Journal of Virology
|
September 15, 2007
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy
Zandrea Ambrose, Sarah Palmer, Valerie F Boltz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques
Fernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Protein Expression and Purification
|
October 24, 2021
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
Wen-Hsiang Chen, Jeroen Pollet, Ulrich Strych, et al.
NPJ Vaccines
|
July 21, 2024
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses
Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R Redd, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Nature Communications
|
June 11, 2026
Statewide multi-year wastewater sequencing reveals dual origins of HIV-1 signal
Justin R Clark, Dylan Chirman, Harihara Prakash, et al.
Vaccine
|
May 14, 2022
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 11, 2020
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Human Vaccines & Immunotherapeutics
|
April 13, 2021
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Page
of 8